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Biallelic loss-of-function MEGF10 mutations lead to MEGF10 myopathy,
also known as early onset myopathy with areflexia, respiratory distress,
and dysphagia (EMARDD). MEGF10 is expressed in muscle satellite cells,
but the contribution of satellite cell dysfunction to MEGF10 myopathy is
unclear. Myofibers and satellite cells were isolated and examined from
Megf10 / and wild-type mice. A separate set of mice underwent repeated
intramuscular barium chloride injections. Megf10 / muscle satellite cells
showed reduced proliferation and migration, while Megf10 / mouse skeletal muscles showed impaired regeneration. Megf10 deficiency is associated
with impaired muscle regeneration, due in part to defects in satellite cell
function. Efforts to rescue Megf10 deficiency will have therapeutic implications for MEGF10 myopathy and other inherited muscle diseases involving
impaired muscle regeneration.

(Received 22 July 2020, revised 18 October
2020, accepted 26 October 2020)
doi:10.1002/2211-5463.13031

MEGF10 is an orphan receptor that is expressed in
developing myoblasts and muscle satellite cells. Biallelic loss-of-function mutations in the encoding gene

MEGF10 cause a recessive congenital muscle disease
called MEGF10 myopathy [1–7]; the classic form of
this disease is also known as early onset myopathy

Abbreviations
AMP, adult muscle precursor; ANOVA, analysis of variance; bHLH, basic helix-loop-helix; Drpr, Draper; EDL, extensor digitorum longus;
EMARDD, early onset myopathy, areflexia, respiratory distress, and dysphagia; IACUC, institutional animal care and use committee; IF,
immunofluorescence; MEGF10 (human) or Megf10 (mouse), multiple EGF-like domains 10; MRF, myogenic regulatory factor; PBS,
phosphate-buffered saline; SEM, standard error of the mean; SSRI, selective serotonin reuptake inhibitor; TA, tibialis anterior.
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with areflexia, respiratory distress, and dysphagia
(EMARDD) [8]. Minicores have been seen on muscle
biopsy in several cases of MEGF10 myopathy [2,5],
and an adult onset form of this disease has also been
described [4,5]. The molecular mechanism of disease in
MEGF10 myopathy/EMARDD involves impaired tyrosine phosphorylation [9] and impaired interactions
between MEGF10 and the Notch pathway [10,11],
whereas the cellular mechanism of disease appears to
involve potential defects in myogenesis, particularly
myoblast proliferation [10] and migration [11], consistent with the congenital onset of disease in the classic
EMARDD phenotype.
Satellite cells are muscle stem cells that are located
between the sarcolemma and the basal lamina of muscle fibers and were first described in frogs [12]. Embryologically, they originate from the dermomyotome cell
population [13]. Satellite cells undergo asymmetric division, yielding both a self-perpetuating cell population
and cells that are destined to fuse with adjacent muscle
fibers to assist with muscle growth and regeneration
[14]. In the settings of muscle injury and chronic muscle
disease, satellite cells help resuscitate injured and regenerating muscle fibers by fusing with them [15]. The regulation of satellite cell states, including quiescence,
activation, proliferation, and differentiation/fusion, is
complex, with many details described but many questions still unanswered [16]. In the context of MEGF10,
prior work has shown that satellite cell dysfunction
contributes to the pathogenesis of MEGF10 myopathy
and that Megf10 is expressed in quiescent and activated
murine satellite cells [10]. Dll1 [17], a Notch ligand,
and myogenin [18] have been shown to be positive regulators of Megf10 expression, whereas the combination
of an Rbpj conditional mutation in Pax3+ myogenic
precursors combined with mutant MyoD downregulate
Megf10 expression [17]. However, it is not yet clear
whether Megf10 deficiency has an impact on key cellular processes such as satellite cell migration, along with
the larger biological process of muscle regeneration.
Experiments on a mouse model of MEGF10 myopathy
as well as satellite cells isolated from these mice will
help answer these questions.
There are several methods used to replicate muscle
injury in mouse models [19]. For the current study, we
selected chemical injury with barium chloride due to
its reliability and low toxicity [20]. A prior study from
our group showed that muscle injury induced by intramuscular barium chloride injections yielded subtle
signs of delayed regeneration in Megf10 / mice compared to wild-type mice [11]. However, repeated intramuscular injections to deplete the satellite cell pool
have not previously been performed [21].

Megf10 in satellite cells and muscle regeneration

A better understanding of the contribution of
MEGF10 to satellite cell function and muscle regeneration, along with the effects of MEGF10 deficiency on
these important processes, could help identify novel
targets for therapeutic strategies for MEGF10 myopathy. If such therapeutic strategies specifically augment
satellite cell function in skeletal muscle, they could also
be applied to a range of muscle diseases associated
with impaired regeneration, including the muscular
dystrophies. The aims of the current study are to
examine patterns of satellite cell detachment from
myofibers, expression patterns of MyoD in these satellite cells, and skeletal muscle regenerative capacity in a
mouse model of MEGF10 myopathy.

Materials and methods
Mouse strains
All animal studies were performed under the auspices of a
protocol approved by the Institutional Animal Care and
Use Committee (IACUC) at the University of Florida.
Megf10+/- mice with a C57BL/6 background were generous
gifts from Jeremy Kay at Duke University and Joshua
Sanes at Harvard University, and were bred to yield
Megf10 / mice. Genotypes were verified as previously
described, and Megf10 deficiency has previously been confirmed in this strain [11,22]. Wild-type C57BL/6J mice were
obtained from Animal Care Services at the University of
Florida. Skeletal muscle specimens for histological analysis
and cell extractions were dissected ex vivo immediately after
IACUC-approved euthanasia procedures.

Single myofiber isolation and culture, with
satellite cell detachment
Individual myofibers were isolated from the extensor digitorum longus (EDL) muscles of 6 Megf10 / and 5 wild-type
mice according to a standard protocol [23]. EDL is a standard
muscle from which to isolate individual myofibers from mice
for satellite cell analysis [23]. Ten to fifteen live myofibers were
dissected from each EDL muscle and then cultured individually in glass chamber slides (ibidi GmbH, Martinsried, Germany) coated with Matrigel (Corning) with serum-rich
medium (20% fetal bovine serum). The satellite cells observed
to be detached from each myofiber were manually counted at
24, 48, and 72 h timepoints to capture detachment and migration prior to differentiation [24].

Immunofluorescence (IF) of myofibers and
satellite cells
At 72 h, the myofibers and satellite cells in glass chamber
slides were washed with phosphate-buffered saline (PBS),
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fixed in prewarmed 4% paraformaldehyde, incubated in
1% glycine in PBS quenching solution to minimize background staining, then permeabilized with 0.1% Triton X100 in PBS. After blocking with 5–10% fetal bovine serum
in PBS, the myofibers and satellite cells were incubated
with primary antibodies to Pax7 (Developmental Studies
Hybridoma Bank) and MyoD (Developmental Studies
Hybridoma Bank and Santa Cruz), then with secondary
Alexa-568 or Alexa-488 conjugated goat anti-rabbit antibodies (Life Technologies) or secondary Alexa-568 antimouse antibodies (Life Technologies). The nuclei were
counterstained with DAPI. Pax7+ and MyoD-+ satellite
cells were counted, and the shortest distance between the
center of each satellite cell to the edge of the myofiber was
measured using ImageJ [25].

times for 2 minutes in xylene. Sections were also stained
with fibronectin using standard methods [28]; fibronectin
quantification was performed using ImageJ [25]. The sections were mounted with Cytoseal 60 (Richard Allan Scientific) and visualized on an Olympus BX51 upright light
microscope.

Statistical analysis
Unpaired t-tests were used to compare Megf10 / and
wild-type groups for the various experiments described
above. Means +/- standard error of the mean (SEM) were
calculated. One-way analysis of variance (ANOVA) was
used to analyze the fibronectin quantification. GraphPad
Prism (GraphPad Software, San Diego, California) was
used for statistical analyses.

IF of satellite cells
Myofibers were cultured on cover slips in culture dishes
and maintained in proliferation media consisting of 20%
fetal bovine serum, 5% chick embryo extract, and 2% penicillin/streptomycin in DMEM (high glucose). At 72 h, the
myofibers were washed away, leaving the activated satellite
cells on the culture dish. IF was performed on the satellite
cells as described above for MyoD, accompanied by
nuclear DAPI counterstaining.

Barium chloride injury
Muscle injury was modeled in 2-month-old mice of both
strains via injection of 50 lL 1.2% barium chloride in sterile water into the right tibialis anterior, with injection of
sterile water into the left tibialis anterior as a control. Tibialis anterior is a standard muscle used for such muscle
injury experiments in mice [26]. To deplete the satellite cell
pool, the injections were performed a total of three times
[21] starting at age 2 months, with gaps of 21–28 days
between injections to permit complete recovery between
injections [27]. Twenty-one days after the third injection,
the mice were euthanized and bilateral tibialis anterior muscles were harvested. The tibialis anterior muscles were
snap-frozen for hematoxylin and eosin staining.

Hematoxylin and eosin histological analyses
Tibialis anterior muscles were dissected immediately ex vivo
from the two mouse strains noted above and then snap-frozen in 2-methylbutane cooled with liquid nitrogen. The
muscle samples were sectioned at 7µm in a cryostat and
transferred to superfrost microscope slides. For hematoxylin and eosin staining, the sections were incubated for
5 minutes in hematoxylin (Leica Biosystems); rinsed with
cold tap water; immersed twice in eosin Y; washed consecutively with 80, 90, and 100% ethanol; and incubated three
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Results
Diminished detachment of Megf10 / satellite
cells from myofibers compared to wild-type cells
Manual counts showed steadily increasing numbers of
satellite cells that had visibly detached from individual
myofibers at 24 h (Fig. 1A), 48 h (Fig. 1B), and 72 h
(Fig. 1C) of culture. Representative images are shown
at 72 hours (Fig. 1D). At each time point, fewer satellite cells were detached from Megf10 / live myofibers
than from wild-type live myofibers, indicating that
Megf10 deficiency is associated with impaired satellite
cell activation and migration.

Deficiency in MyoD expression of Megf10
satellite cells

/

To quantify satellite cell activation and migration patterns in greater detail, IF was performed to identify
Pax7265947092+/MyoD619236543+ cells associated
with individual myofibers, including those attached to
and detached from the myofibers, at 72 h of culture
(Fig. 2A). Manual counts of attached and detached
Pax7+/MyoD+ cells showed that these cells were less
abundant for Megf10 / myofibers compared to wildtype myofibers (Fig. 2B). Measurements of distances
migrated by the Pax7+/MyoD+ cells at the same timepoint showed less robust migration for cells associated
with Megf10 / myofibers compared to wild-type
myofibers (Fig. 2C). Satellite cells detached from myofibers were cultured separately, showing less abundant
MyoD expression among DAPI-positive nuclei of
Megf10 / satellite cells compared to wild-type satellite cells (Fig. 2D,E). These results provide additional
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Fig. 1. (A) Single intact live myofibers were isolated from wild-type and Megf10 / mice and cultured in serum-rich medium in glass
chamber slides. Detached satellite cells were counted for each myofiber at (A) 24, (B) 48, and (C) 72 h timepoints. Each dot represents the
satellite cell count for one myofiber. The number of myofibers evaluated were: (A) wild-type, n = 70 myofibers; Megf10 / , n = 70
myofibers; (B) wild-type, n = 52 myofibers; Megf10 / , n = 70 myofibers; (C) wild-type, n = 47 myofibers; Megf10 / , n = 47 myofibers.
Comparisons between wild-type and Megf10 / myofiber counts were performed at each time point by unpaired t-tests; ***, P < 0.001. (D)
Representative images are shown at 72 h. Arrows indicate satellite cells that have detached and migrated from the isolated myofibers.
Scale bar, 50 lm.

evidence that Megf10 deficiency is associated with
reduced satellite cell activation and migration.
Reduced regeneration potential and increased
fibrosis in Megf10 / mice after muscle injury
Three sequential barium chloride injections into mouse
tibialis anterior were performed for both wild-type and
Megf10 / mice, with saline intramuscular injections
serving as controls (Fig. 3A). Hematoxylin and eosin

staining of representative sections from the injected muscles revealed significantly reduced regeneration potential
with pronounced pockets of atrophic fibers and greater
overall fiber size variability in Megf10 / tibialis anterior
muscles injected with barium chloride compared to wildtype tibialis anterior muscles (Fig. 3B). Fibronectin
staining was performed on muscle sections to demonstrate the degree of fibrosis in the injected tibialis anterior
muscles. Greater densities of fibronectin were measured
muscles
via ImageJ quantification in Megf10 /
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Fig. 2. (A) Representative individual and merged images of satellite cells stained with anti-Pax7 (red), anti-MyoD (green), and DAPI at 72 h
of myofiber culture. Arrows indicate satellite cells expressing both Pax7 and MyoD. Scale bar = 50 lm. (B) Scatter plot showing numbers of
Pax7+/MyoD+ satellite cells associated with individual myofibers at 72 h. Each dot represents the cell count from one myofiber: wild-type,
n = 67; Megf10 / , n = 71. The comparison of the cell counts between the wild-type and Meg10 / groups was performed by an unpaired
t-test; ***, P < 0.001. (C) The distances between Pax7169005038+/MyoD865006223+ satellite cells and their associated myofiber were
measured at 72 h of culture. Each dot represents one Pax7+/MyoD+ cell. Arbitrary units noted on y-axis. Wild-type: n = 471 cells counted
from 67 fibers; Megf10 / : n = 165 cells counted from 71 fibers. The comparison of the migration distances between the wild-type and
Megf10 / groups was performed by an unpaired t-test; ***, P < 0.001. (D) MyoD+ nuclei are less abundant in Megf10 / detached
satellite cells compared to wild-type cells. (E) Quantification of MyoD+ nuclei in proliferating satellite cells. Megf10 / cells have significantly
reduced MyoD+ nuclei in plated satellite cells after 96 h of single myofiber culture. Scatter plots represent counts from n = 10 images;
mean  SEM shown; ****, P < 0.0001.

compared to wild-type muscles (Fig. 3C). A representative IF image demonstrates the thicker bands of fibronectin seen in Meg10 / muscle sections compared to wildtype muscle sections (Fig. 3D).

Discussion
In the decade since the gene MEGF10 was first associated with a distinct human muscle disease, it has
become apparent that the protein product MEGF10
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plays a key role in satellite cell function. Over time,
various aspects of MEGF10’s biochemical and cellular
functions have been elucidated. The current study fills
in another piece to the puzzle and provides further
details on how MEGF10 deficiency affects satellite cell
behavior and offers novel information regarding the
impact of such a deficiency on skeletal muscle regenerative capacity.
Satellite cells are mononuclear progenitor stem cells
in skeletal muscle that make key contributions to the
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Fig. 3. (A) Timeline of mouse injury
experiments, showing intervals between
birth, 3 sequential barium chloride and
saline (control) injections into tibialis
anterior, and euthanasia followed by tissue
harvesting. (B) Hematoxylin and eosin
staining of sections from tibialis anterior
muscles that were injected with either
barium chloride or saline in wild-type and
Megf10 / mice. Arrows in the barium
chloride Megf10 / image indicate
clusters of small myofibers with
internalized nuclei; such clusters are not
present in the barium chloride wild-type
image. Scale bar, 100lm. (C) Fibrosis
quantification was performed on 5 images
of fibronectin stained sections of tibialis
anterior muscles injected with barium
chloride in wild-type and Megf10 / mice.
The percent fibrosis index was calculated
as fibrotic area/total area 9 100, indicated
as percentages. An unpaired t-test and
one-way ANOVA both yielded P < 0.0001
between wild-type and Megf10 / groups.
Scatter plots represent fibrosis indices
from n = 5 images; mean  SEM shown;
****, P < 0.0001. (D) Representative IF
images of muscle sections show
fibronectin (green) with DAPI (blue)
counterstaining in barium chloride injected
tibialis anterior muscles from wild-type and
Megf10 / mice. Scale bar, 100 lm.

process of muscle repair after injury. The name ‘satellite cell’ was derived from the original observation
that these cells are found in the niche between the
basal lamina and sarcolemma of a myofiber [12]. The
satellite cell cycle includes symmetric and asymmetric
components, the former consisting of self-renewal
within the quiescent state [29] and the latter leading
to a terminal exit from that state. Quiescent and selfrenewing satellite cells can be identified by the detection of several distinct protein markers, most commonly the paired box 7 (Pax7) transcription factor in
their nuclei [30]. Of particular relevance to Megf10,
which interacts with Notch1 [10,11], extrinsic Notch
signaling is critical for the maintenance of the quiescent state [31,32] and Notch1 activation promotes
proliferation of satellite cells [14]. The classic stages

of an exit from the quiescent state are demarcated by
the expression patterns of key myogenic regulatory
factors (MRFs) that are all basic helix-loop-helix
(bHLH) transcription factors [33]: Myf5 [34], MyoD
[35], myogenenin [36], and Mrf4 [37]. All four of
these MRFs are induced during various stages of
satellite cell activation [38,39]. For our studies, we
focused on Pax7+/MyoD+ cells as the co-expression
of these two markers is generally accepted as indicating the presence of activated satellite cells that proliferate and migrate [40], and our prior work indicated
that Megf10 deficiency is associated with impaired
proliferation and migration in C2C12 myoblasts and
primary mouse myoblasts [11], suggesting a role for
Megf10 in this early stage of the satellite cell myogenic pathway.
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In this context, what role might MEGF10 play in
the regulation of the early stages of the satellite cell
myogenic pathway? It is an orphan receptor that is
expressed at the cell surface with a single transmembrane domain and thus is not an MRF. It interacts
with Notch1 and thus likely performs an extrinsic regulatory task [10], though the interaction occurs at both
proteins’ intracellular domains [11]. Our current data
show that Megf10 deficiency impairs migration of
Pax7+/MyoD+ activated satellite cells and is associated
with reduced numbers of MyoD + cells, providing further evidence that Megf10 contributes to an early stage
of satellite cell activation during which the cells
migrate to target myofibers. This information could
help explain the persistent nature of the clinical manifestations of MEGF10 myopathy, as muscle function
generally does not improve in human patients affected
by this disease [1,2].
In previous studies, we have shown that downregulation of draper (drpr), the Drosophila homolog of
Megf10, in quiescent adult muscle precursors (satellite
cell-like AMPs) leads to decreased motor activity in
corresponding mutant flies [41]. These cells, however,
are insensitive to drpr/Megf10 overexpression, which
is deleterious later in myogenesis, that is, at the
migration/differentiation stages (suggesting that Drpr
levels are finely tuned during these steps) [42]. It is
well established that drpr plays a crucial role in mediating the migration of glia toward injured neurons
[43,44], as well as the migration of immune cells
toward tissue wound [45]. Whether a parallel drpr/
Megf10-dependent molecular mechanism participates
in regulating the migration of satellite cells toward
developing, or injured, muscle fibers remains to be
elucidated. Regeneration of injured muscle has been
reported in Drosophila [46]. The fly may provide a
useful model in which to further elucidate the conserved pathways downstream of drpr/Megf10 that
contribute to muscle development and potentially
repair. Future Drosophila studies could address the
question of satellite cell migration by examining the
effects of drpr deficiency on the migration patterns of
AMPs, which behave much as muscle satellite cells do
in mammals [47].
Regardless of the exact cellular role of Megf10 in
the satellite cell cycle, our data show a clear impact on
skeletal muscle regeneration. Impaired muscle regeneration has significant chronic consequences for muscle
homeostasis. Thus, MEGF10 bears further investigation as a therapeutic target, not only for MEGF10
deficiency itself, but also for other inherited muscle
diseases, including various forms of muscular
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dystrophy. Recently, we published a study that identified selective serotonin reuptake inhibitors, notably
sertraline, as having a beneficial effect on cellular and
in vivo (i.e., Drosophila and zebrafish) models of
Megf10 deficiency [48]. Serotonin did not replicate this
effect in Drosophila, whereas sertraline behaved as a
Notch pathway agonist in these cellular models, suggesting another link between MEGF10 and the Notch
pathway [48] in addition to evidence from various
selective serotonin reuptake inhibitors (SSRIs) in other
contexts [49–52]. Further investigations of the effects
of sertraline on Megf10 deficiency should include
detailed mouse experiments that could both confirm
the therapeutic effect and also elucidate the interactions between Megf10 and the satellite cell cycle. These
studies could then be supplemented by examinations
of the effects of sertraline on mouse models for other
inherited muscle diseases, to explore potential broader
applications of manipulating this therapeutic target.
Overall, more precise information regarding the relationship between MEGF10 and the Notch pathway
could be drawn out by exploring potential interactions
with other Notch pathway components, as well as with
protein
O-glucosyltransferase
1
(encoded
by
POGLUT1 and previously known as Rumi); the latter
is associated with muscular dystrophy and is also
known to be a regulator of the Notch pathway [53,54].
POGLUT1 mutations have been associated with a
reduction in muscle satellite cells [55]. Detailed fluorescence activated cell sort (FACS) experiments could
also elucidate how MEGF10 deficiency could alter
early stages of the satellite cell cycle. Such knowledge
could then lead to the development of standardized
in vitro markers to gauge potential therapeutic effects
of sertraline or other candidate therapies for MEGF10
myopathy. MEGF10 could provide a therapeutic target for manipulation of Notch signaling to augment
skeletal muscle regenerative capacity via satellite cell
enhancement, which could lead to new treatments not
only for MEGF10 myopathy, but also for other inherited muscle diseases accompanied by impaired muscle
regeneration, including a broad range of muscular dystrophies.

Acknowledgements
This work was supported by NIH R01 NS080929 and
the Ferlita Family Fund.

Conflict of interest
The authors declare no conflict of interest.

FEBS Open Bio 11 (2021) 114–123 ª 2020 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.

C. Li et al.

Megf10 in satellite cells and muscle regeneration

Author contribution
PBK conceived and supervised the study and designed
experiments. CL, MS, RMD, and KAM performed
experiments. CL, DV, MS, CAP, and PBK analyzed
data. CL, DV, MS, ID, CAP, and PBK interpreted
data and wrote the manuscript.

8

9

Data Availability Statement
The corresponding author will share data upon reasonable request.

10

References
1 Logan CV, Lucke B, Pottinger C, Abdelhamed ZA,
Parry DA, Szymanska K, Diggle CP, van Riesen A,
Morgan JE, Markham G et al. (2011) Mutations in
MEGF10, a regulator of satellite cell myogenesis, cause
early onset myopathy, areflexia, respiratory distress and
dysphagia (EMARDD). Nat Genet 43, 1189–1192.
2 Boyden SE, Mahoney LJ, Kawahara G, Myers JA,
Mitsuhashi S, Estrella EA, Duncan AR, Dey F,
DeChene ET, Blasko-Goehringer JM et al. (2012)
Mutations in the satellite cell gene MEGF10 cause a
recessive congenital myopathy with minicores.
Neurogenetics 13, 115–124.
3 Alabdullatif MA, Al Dhaibani MA, Khassawneh MY
and El-Hattab AW (2017) Chromosomal microarray in
a highly consanguineous population: diagnostic yield,
utility of regions of homozygosity, and novel mutations.
Clin Genet 91, 616–622.
4 Harris E, Marini-Bettolo C, T€
opf A, Barresi R,
Polvikoski T, Bailey G, Charlton R, Tellez J,
MacArthur D, Guglieri M et al. (2018) MEGF10
related myopathies: a new case with adult onset disease
with prominent respiratory failure and review of
reported phenotypes. Neuromuscul Disord 28, 48–53.
5 Liewluck T, Milone M, Tian X, Engel AG, Staff NP
and Wong LJ (2016) Adult-onset respiratory
insufficiency, scoliosis, and distal joint hyperlaxity in
patients with multiminicore disease due to novel Megf10
mutations. Muscle Nerve 53, 984–988.
6 Pierson TM, Markello T, Accardi J, Wolfe L, Adams
D, Sincan M, Tarazi NM, Fajardo KF, Cherukuri PF,
Bajraktari I et al. (2013) Novel SNP array analysis and
exome sequencing detect a homozygous exon 7 deletion
of MEGF10 causing early onset myopathy, areflexia,
respiratory distress and dysphagia (EMARDD).
Neuromuscul Disord 23, 483–488.
7 Takayama K, Mitsuhashi S, Shin J-Y, Tanaka R, Fujii
T, Tsuburaya R, Mukaida S, Noguchi S, Nonaka I and
Nishino I (2016) Japanese multiple epidermal growth
factor 10 (MEGF10) myopathy with novel mutations: a

11

12
13

14

15

16

17

18

19

20

phenotype-genotype correlation. Neuromuscul Disord 26,
604–609.
Hartley L, Kinali M, Knight R, Mercuri E, Hubner C,
Bertini E, Manzur Ay, Jimenez-Mallebrera C, Sewry Ca
and Muntoni F (2007) A congenital myopathy with
diaphragmatic weakness not linked to the SMARD1
locus. Neuromuscul Disord 17, 174–179.
Mitsuhashi S, Mitsuhashi H, Alexander MS, Sugimoto
H and Kang PB (2013) Cysteine mutations cause
defective tyrosine phosphorylation in MEGF10
myopathy. FEBS Lett 587, 2952–2957.
Holterman CE, Le Grand F, Kuang S, Seale P and
Rudnicki MA (2007) Megf10 regulates the progression
of the satellite cell myogenic program. J Cell Biol 179,
911–922.
Saha M, Mitsuhashi S, Jones MD, Manko K, Reddy
HM, Bruels CC, Cho K-A, Pacak CA, Draper I and
Kang PB (2017) Consequences of MEGF10 deficiency
on myoblast function and Notch1 interactions. Hum
Mol Genet 26, 2984–3000.
Mauro A (1961) Satellite cell of skeletal muscle fibers. J
Biophys Biochem Cytol 9, 493–495.
Gros J, Manceau M, Thome V and Marcelle C (2005)
A common somitic origin for embryonic muscle
progenitors and satellite cells. Nature 435, 954–958.
Conboy IM and Rando TA (2002) The regulation of
Notch signaling controls satellite cell activation and cell
fate determination in postnatal myogenesis. Dev Cell 3,
397–409.
Chou SM and Nonaka I (1977) Satellite cells and
muscle regeneration in diseased human skeletal muscles.
J Neurol Sci 34, 131–145.
Dumont NA, Bentzinger CF, Sincennes MC and
Rudnicki MA (2015) Satellite cells and skeletal muscle
regeneration. Compr Physiol 5, 1027–1059.
Brohl D, , Vasyutina E, Czajkowski MT, Griger J,
Rassek C, Rahn H-P, Purf€
urst B, Wende H and
Birchmeier C (2012) Colonization of the satellite cell
niche by skeletal muscle progenitor cells depends on
Notch signals. Dev Cell 23, 469–481.
Park SY, Yun Y, Kim MJ and Kim IS (2014)
Myogenin is a positive regulator of MEGF10
expression in skeletal muscle. Biochem Biophys Res
Commun 450, 1631–1637.
Hardy D, Besnard A, Latil M, Jouvion G, Briand D,
Thepenier C, Pascal Q, Guguin A, Gayraud-Morel B,
Cavaillon J-M et al. (2016) Comparative study of injury
models for studying muscle regeneration in mice. PLoS
One 11, e0147198.
Morton AB, Norton CE, Jacobsen NL, Fernando CA,
Cornelison DDW and Segal SS (2019) Barium chloride
injures myofibers through calcium-induced proteolysis
with fragmentation of motor nerves and microvessels.
Skelet Muscle 9, 27.

FEBS Open Bio 11 (2021) 114–123 ª 2020 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.

121

C. Li et al.

Megf10 in satellite cells and muscle regeneration

21 Schaaf GJ, van Gestel TJM, in ‘t Groen SLM, de Jong
B, Boomaars B, Tarallo A, Cardone M, Parenti G, van
der Ploeg AT and Pijnappel WWMP (2018) Satellite
cells maintain regenerative capacity but fail to repair
disease-associated muscle damage in mice with Pompe
disease. Acta Neuropathol Commun 6, 119.
22 Kay JN, Chu MW and Sanes JR (2012) MEGF10 and
MEGF11 mediate homotypic interactions required for
mosaic spacing of retinal neurons. Nature 483, 465–469.
23 Pasut A, Jones AE and Rudnicki MA (2013) Isolation
and culture of individual myofibers and their satellite
cells from adult skeletal muscle. J Vis Exp e50074.
24 Keire P, Shearer A, Shefer G and Yablonka-Reuveni Z
(2013) Isolation and culture of skeletal muscle
myofibers as a means to analyze satellite cells. Methods
Mol Biol 946, 431–468.
25 Schneider CA, Rasband WS and Eliceiri KW (2012)
NIH image to ImageJ: 25 years of image analysis. Nat
Methods 9, 671–675.
26 Cornelison DD, Wilcox-Adelman SA, Goetinck PF,
Rauvala H, Rapraeger AC and Olwin BB (2004)
Essential and separable roles for Syndecan-3 and
Syndecan-4 in skeletal muscle development and
regeneration. Genes Dev 18, 2231–2236.
27 Tierney MT and Sacco A (2016) Inducing and
evaluating skeletal muscle injury by notexin and barium
chloride. Methods Mol Biol 1460, 53–60.
28 Hadi AM, Mouchaers KT, Schalij I, Grunberg K,
Meijer GA, Vonk-Noordegraaf A, van der Laarse WJ
and Belien JA (2010) Rapid quantification of
myocardial fibrosis: a new macro-based automated
analysis. Anal Cell Pathol (Amst) 33, 257–269.
29 Kuang S, Kuroda K, Le Grand F and Rudnicki MA
(2007) Asymmetric self-renewal and commitment of
satellite stem cells in muscle. Cell 129, 999–1010.
30 Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A,
Gruss P and Rudnicki MA (2000) Pax7 is required for
the specification of myogenic satellite cells. Cell 102,
777–786.
31 Mourikis P, Sambasivan R, Castel D, Rocheteau P,
Bizzarro V and Tajbakhsh S (2012) A critical
requirement for notch signaling in maintenance of the
quiescent skeletal muscle stem cell state. Stem Cells 30,
243–252.
32 Bjornson CR, Cheung TH, Liu L, Tripathi PV, Steeper
KM and Rando TA (2012) Notch signaling is necessary
to maintain quiescence in adult muscle stem cells. Stem
Cells 30, 232–242.
33 Zammit PS (2017) Function of the myogenic regulatory
factors Myf5, MyoD, Myogenin and MRF4 in skeletal
muscle, satellite cells and regenerative myogenesis.
Semin Cell Dev Biol 72, 19–32.
34 Braun T, Buschhausen-Denker G, Bober E, Tannich E
and Arnold HH (1989) A novel human muscle factor

122

35

36

37

38

39

40

41

42

43

44

45

46

47

48

related to but distinct from MyoD1 induces myogenic
conversion in 10T1/2 fibroblasts. EMBO J 8, 701–709.
Davis RL, Weintraub H and Lassar AB (1987)
Expression of a single transfected cDNA converts
fibroblasts to myoblasts. Cell 51, 987–1000.
Wright WE, Sassoon DA and Lin VK (1989)
Myogenin, a factor regulating myogenesis, has a
domain homologous to MyoD. Cell 56, 607–617.
Rhodes SJ and Konieczny SF (1989) Identification of
MRF4: a new member of the muscle regulatory factor
gene family. Genes Dev 3, 2050–2061.
Maley MA, Davies MJ and Grounds MD (1995)
Extracellular matrix, growth factors, genetics: their
influence on cell proliferation and myotube formation
in primary cultures of adult mouse skeletal muscle. Exp
Cell Res 219, 169–179.
Smith CK 2nd, Janney MJ and Allen RE (1994)
Temporal expression of myogenic regulatory genes
during activation, proliferation, and differentiation of
rat skeletal muscle satellite cells. J Cell Physiol 159,
379–385.
Zammit PS, Golding JP, Nagata Y, Hudon V,
Partridge TA and Beauchamp JR (2004) Muscle
satellite cells adopt divergent fates: a mechanism for
self-renewal? J Cell Biol 166, 347–357.
Draper I, Mahoney LJ, Mitsuhashi S, Pacak CA,
Salomon RN and Kang PB (2014) Silencing of drpr
leads to muscle and brain degeneration in adult
Drosophila. Am J Pathol 184, 2653–2661.
Draper I, Saha M, Stonebreaker H, Salomon RN,
Matin B and Kang PB (2019) The impact of Megf10/
Drpr gain-of-function on muscle development in
Drosophila. FEBS Lett 593, 680–696.
Doherty J, Sheehan AE, Bradshaw R, Fox AN, Lu TY
and Freeman MR (2014) PI3K signaling and Stat92E
converge to modulate glial responsiveness to axonal
injury. PLoS Biol 12, e1001985.
Ray A, Speese SD and Logan MA (2017) Glial draper
rescues abeta toxicity in a Drosophila model of
Alzheimer’s disease. J Neurosci 37, 11881–11893.
Evans IR, Rodrigues FS, Armitage EL and Wood W
(2015) Draper/CED-1 mediates an ancient damage
response to control inflammatory blood cell migration
in vivo. Curr Biol 25, 1606–1612.
Chaturvedi D, Reichert H, Gunage RD and
VijayRaghavan K (2017) Identification and functional
characterization of muscle satellite cells in Drosophila.
Elife 6.
Figeac N, Daczewska M, Marcelle C and Jagla K
(2007) Muscle stem cells and model systems for their
investigation. Dev Dyn 236, 3332–3342.
Saha M, Rizzo SA, Ramanathan M, Hightower RM,
Santostefano KE, Terada N, Finkel RS, Berg JS,
Chahin N, Pacak CA et al. (2019) Selective serotonin

FEBS Open Bio 11 (2021) 114–123 ª 2020 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.

C. Li et al.

49

50

51

52

reuptake inhibitors ameliorate MEGF10 myopathy.
Hum Mol Genet 28, 2365–2377.
Cray JJ Jr, Weinberg SM, Parsons TE, Howie RN,
Elsalanty M and Yu JC (2014) Selective serotonin
reuptake inhibitor exposure alters osteoblast gene
expression and craniofacial development in mice. Birth
Defects Res A Clin Mol Teratol 100, 912–923.
Chen HF, Pan XL, Wang JW, Kong HM and Fu YM
(2014) Protein-drug interactome analysis of SSRImediated neurorecovery following stroke. Biosystems
120, 1–9.
Sui Y, Zhang Z, Guo Y, Sun Y, Zhang X, Xie C, Li Y
and Xi G (2009) The function of Notch1 signaling was
increased in parallel with neurogenesis in rat
hippocampus after chronic fluoxetine administration.
Biol Pharm Bull 32, 1776–1782.
Ghareghani M, Zibara K, Sadeghi H, Dokoohaki S,
Sadeghi H, Aryanpour R and Ghanbari A (2017)
Fluvoxamine stimulates oligodendrogenesis of cultured

Megf10 in satellite cells and muscle regeneration

neural stem cells and attenuates inflammation and
demyelination in an animal model of multiple sclerosis.
Sci Rep 7, 4923.
53 Acar M, Jafar-Nejad H, Takeuchi H, Rajan A, Ibrani
D, Rana NA, Pan H, Haltiwanger RS and Bellen HJ
(2008) Rumi is a CAP10 domain glycosyltransferase
that modifies Notch and is required for Notch
signaling. Cell 132, 247–258.
54 Fernandez-Valdivia R, Takeuchi H, Samarghandi A,
Lopez M, Leonardi J, Haltiwanger RS and Jafar-Nejad
H (2011) Regulation of mammalian Notch signaling
and embryonic development by the protein Oglucosyltransferase Rumi. Development 138, 1925–1934.
55 Servian-Morilla E, Cabrera-Serrano M, Johnson K,
Pandey A, Ito A, Rivas E, Chamova T, Muelas N,
Mongini T, Nafissi S et al. (2020) POGLUT1 biallelic
mutations cause myopathy with reduced satellite cells,
alpha-dystroglycan hypoglycosylation and a distinctive
radiological pattern. Acta Neuropathol 139, 565–582.

FEBS Open Bio 11 (2021) 114–123 ª 2020 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of
Federation of European Biochemical Societies.

123

